Cas-CLOVER is a novel high-fidelity nuclease for safe and robust generation of TSCM-enriched allogeneic CAR-T cells
Author:
Publisher
Elsevier BV
Subject
Drug Discovery,Molecular Medicine
Reference56 articles.
1. T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia;Kalos;Sci. Transl. Med.,2011
2. T cells expressing an anti-B-cell maturation antigen chimeric antigen receptor cause remissions of multiple myeloma;Ali;Blood,2016
3. Lymphocyte depletion and repopulation after chemotherapy for primary breast cancer;Verma;Breast Cancer Res.,2016
4. Genome engineering using the CRISPR-Cas9 system;Ran;Nat. Protoc.,2013
5. High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity;Pattanayak;Nat. Biotechnol.,2013
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Allogeneic CAR-T Therapy Technologies: Has the Promise Been Met?;Cells;2024-01-12
2. mRNA‐based chimeric antigen receptor T cell therapy: Basic principles, recent advances and future directions;Interdisciplinary Medicine;2023-12-29
3. The paths and challenges of “off-the-shelf” CAR-T cell therapy: An overview of clinical trials;Biomedicine & Pharmacotherapy;2023-12
4. The CAR macrophage cells, a novel generation of chimeric antigen-based approach against solid tumors;Biomarker Research;2023-11-28
5. Precision genetics tools for genetic improvement of banana;The Plant Genome;2023-11-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3